Overall rank by patents
#24,985
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 13 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).
The verdict
According to USPTO PatentsView, Perceptimed ranks #24,985 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R24985 · US Corporation #24,985 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Pattern Bioscience, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Perceptimed · this assignee
35 score
3D Lighting Innovati… · lowest
7 score
What this shows Perceptimed's Innovation Score is 35.1/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Perceptimed, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 63.6% of grants classified under A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2016. By volume, Perceptimed sits between Pattern Bioscience, Inc. and Phagenesis Limited.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Pattern Bioscience, Inc.
11 patents
PendoTECH
11 patents
PeptiDream Inc.
11 patents
Peptilogics, Inc.
11 patents
Percutaneous Cardiovascular Solutions Pty Ltd
11 patents
Pericom Semiconductor Corporation
11 patents
Peter MacCallum Cancer Institute
11 patents
Phagenesis Limited
11 patents
PerceptiMed, Inc.
11 patents
What this shows Perceptimed holds 11 patents at rank #24,993, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,993 in granted patent volume.
Other assignees with the most granted patents in Perceptimed's primary technology class.
Perceptimed's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 9.1% |
| 2017 | 1 | 9.1% |
| 2018 | 1 | 9.1% |
| 2019 | 5 | 45.5% |
| 2020 | 3 | 27.3% |
Top 13 of 13 technology areas
Overall rank by patents
#24,985
of 50,000 tracked assignees
35.1 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.